Bionpharma Atovaquone Oral Suspension - recalled due to Cohnella bacteria, United States
2 weeks ago •source fda.gov • details
Recall notice
3 years ago • business
Regulatory Report
701 South Harbor Boulevard, Fullerton, 92832 California, United States
1. T8 CCR § 3205(c) - Employer has no COVID-19 Prevention plan enforced in the workplace. Employees concerned with potential exposure to COVID-19 in the workplace. 2. T8 CCR § 3205(c)(6)(A) - Employer not enforcing physical distancing protocol in the facility. Owners encourage potlucks and weekly lunch gatherings disregarding safe physical distance among employees. 3. T8 CCR § 3205(c)(7)(A) - Employer not enforcing face coverings mandate in the workplace.2 weeks ago •source fda.gov • details
Recall notice
1 day ago •reported by user-jdtk5191 • details
4 weeks ago •reported by user-bttnb287 • details
2 weeks ago •reported by user-gvfpb533 • details
2 days ago •reported by user-kmbj7529 • details
4 weeks ago •reported by user-tbjg7863 • details
2 weeks ago •reported by user-bkjf1497 • details
1 week ago •source fda.gov • details
Recall notice
2 weeks ago •reported by user-nnwjt741 • details
2 weeks ago •reported by user-hqfr4982 • details
Search